Physician profile
Jess A Miller
NPI 1033178231
$2,458.57
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,476 · 2020: $329 · 2021: $267 · 2022: $245 · 2024: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $141.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $432.89 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $267.76 | 2019-2022 | |
| Abbvie INC. | $225.26 | 2019-2024 | |
| Genzyme Corporation | $206.36 | 2019-2024 | |
| Boston Scientific Corporation | $145.53 | 2020 | |
| Alexion Pharmaceuticals, INC. | $141.35 | 2019-2020 | |
| Amgen INC. | $122.33 | 2019-2021 | |
| Emd Serono, INC. | $110.00 | 2019 | |
| Livanova USA, INC. | $104.09 | 2019 | |
| Acadia Pharmaceuticals INC | $101.52 | 2019-2020 | |
| Genentech USA, INC. | $83.35 | 2019-2020 | |
| Celgene Corporation | $63.55 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $61.95 | 2019 | |
| Amneal Pharmaceuticals LLC | $60.82 | 2019-2022 | |
| Allergan, INC. | $55.39 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $34.24 | 2019-2020 | |
| Tersera Therapeutics LLC | $32.76 | 2019 | |
| Ucb, INC. | $31.21 | 2019 | |
| Neurocrine Biosciences, INC. | $30.16 | 2019 | |
| Abbott Laboratories | $21.94 | 2022 | |
| Acorda Therapeutics, INC | $18.75 | 2020 | |
| Upsher-Smith Laboratories LLC | $18.71 | 2019 | |
| Merz North America, INC. | $15.93 | 2019 | |
| Kyowa Kirin, INC. | $14.08 | 2020 | |
| Adamas Pharmaceuticals, INC. | $13.48 | 2021 | |
| Grifols USA, LLC | $11.83 | 2019 | |
| Ge Healthcare | $11.30 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.19 | 2021 | |
| Janssen Pharmaceuticals, INC | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jess Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.